About
LungHealth is a company that is clinically fronted by practising NHS clinicians who are Respiratory Consultants. Our interest lies in digital solutions supporting accurate diagnosis in Respiratory disease for COPD, Sleep and Asthma. LungHealth has created a product that assists specialist and non-specialist healthcare professionals to deliver a full and thorough guideline level review. Management decisions always remain with the clinician, but the software prompts to consider what the guidelines would suggest at every step of the patient review. The software can be adapted to any specific country or locality guidelines.
COPD, Asthma and Obstructive Sleep Apnoea constitute a significant burden in terms of healthcare problems globally. Getting an accurate diagnosis is challenging and furthermore, there remains the challenge of delivering guideline level care at each individual patient consultation. Given the potential difficulties in accessing specialist care in many countries, our digital expert Clinical Decision Support EcoSystem with remote capability offers improvements in patient pathways, reduction in variation of care, resulting in accurate diagnosis and greater implementation of guideline level care.
Key Facts
The Lunghealth software is cited on multiple occasions in the NHS Respiratory Medicine GIRFT Programme National Specialty Report August 2021 as examples of technological innovation
Successes in UK/NHS
Sleep: Aintree University Hospital • Dramatically reduced waiting times • Efficiently prioritising ‘must be seen’ patients for consultant review • Achieved an 86% reduction in clinic numbers for patients with OSA/OHS • Freed up 12 PA of consultant time per week • Created a management dashboard that tracks patients at every step of the pathway Asthma: Health Innovation Manchester • Pilot study targeting Health Inequality in Asthma • The conclusions of the preliminary evaluation in 247 patients have demonstrated that the introduction of clinical decision support software in the form of a computer guided consultation when conducting Asthma reviews within primary care is not only feasible but leads also to increased implementation of guideline level standard of care integral to improving patient outcomes and in decreasing health inequality. COPD: NHS Bedfordshire CCG • 17 practices; 847 patients • Following review with the Clinical Guided Consultation, 18% currently on COPD registers were found not to have the diagnosis of COPD (McNemar’s test; p<0.001). • In those who were diagnosed with COPD, those found to have adequate inhaler technique and a written COPD management plan increased from 68% to 94.8% and 44.4% to 92.1% respectively from pre to post LungHealth review (McNemar’s test; p<0.001). • 12% of the cohort were referred for Smoking Cessation and an additional 8.1% of subjects diagnosed with COPD were referred for pulmonary rehabilitation compared to normal care. • One or more COPD medications was discontinued in 43% (382/847) whilst new COPD medication was commenced in 29% (244/847).Company details
Solutions
Augmenting healthcare professionals
Delivering advanced patient care
Providing advanced screening and diagnostics
Specialism
Decision Support and treatment planning
Digitally-enabled out of hospital care
Specialised diagnostics
Company details

Want to connect with this innovator?
Make an enquiryWebsite
www.lunghealth.co.ukDesired Markets
USA, Canada, Australia, New Zealand, Japan, India, South Africa
Desired customer types
Sleep: hospitals, government health systems, private groups, dentists Asthma: hospital, government health systems, private groups, primary care COPD: hospital, government health systems, private groups, primary care